Skip to content
Open access

Correction: Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

Oct 2026 · Frontiers in Pharmacology · Vol 17 · 0 citations
Medicine

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1187066.].

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.